3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
2
Sponsor Class
OTHER
14
NIH
3
NETWORK
2
OTHER_GOV
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Gastrointestinal
2
Plasma cell
1
Lymphoid
1
Breast
1
Conditions
Sarcoma
2
Bone Neoplasms
1
Interventions
Radiotherapy
35
Doxorubicin
30
Ifosfamide
29
Cyclophosphamide
24
Vincristine
23
Filgrastim
23
Etoposide
20
Temozolomide
14
Granulocyte Colony-Stimulating Factor
14
Dactinomycin
11
Cisplatin
11
Trabectedin
10
Methotrexate
10
Gene Expression Profiling
10
Radiation
9
Imatinib Mesylate
9
Surgical Procedures, Operative
8
Polymerase Chain Reaction
8
Irinotecan
8
Specimen Handling
7
Paclitaxel
7
Chemotherapy, Adjuvant
7
Mesna
6
Immunohistochemistry
6
Gemcitabine
6
Carmustine
6
Biopsy
6
sargramostim
5
pegfilgrastim
5
etoposide phosphate
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
olaparib
×
Sarcoma
×
Clear all
NCT03838744
2024-12-04
TOMAS2
Italian Sarcoma Group
Phase 2
Completed
130 enrolled
NCT02398058
2021-04-14
TOMAS
Italian Sarcoma Group
Phase 1
Completed
50 enrolled